SciVision Biotech Inc. (TPE:1786)
Taiwan · Delayed Price · Currency is TWD 49.20
+0.10 (0.20%)
Jul 30, 2026, 12:34 PM CST
SciVision Biotech Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 887.61 | 886.62 | 883.31 | 712.99 | 557.35 | 505.54 |
Revenue Growth | -0.53% | 0.38% | 23.89% | 27.93% | 10.25% | 8.28% |
Gross Profit Gross Profit Growth | 641.43 | 638.39 | 655.68 | 512.49 | 371.87 | 341.84 |
Operating Income Operating Income Growth | 150.62 | 189.92 | 248.11 | 199.64 | 134.61 | 121.94 |
Net Income Net Income Growth | 127.43 | 162.34 | 242.25 | 177.9 | 141.72 | 101.72 |
Earnings Per Share EPS Growth | 1.71 | 2.18 | 3.30 | 2.41 | 1.92 | 1.51 |
EPS Growth | -48.93% | -34.03% | 37.15% | 25.26% | 27.30% | -20.11% |
| Fiscal Year | TTM | FY 2025 | FY 2024 |
|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
Medical Device Manufacturing Department Medical Device Manufacturing Department Growth | 838.35 | 852.27 | 881.23 |
Beauty Management Service Department Beauty Management Service Department Growth | 80.41 | 66.92 | 19.43 |
Adjustment and Elimination Adjustment and Elimination Growth | -31.15 | -32.56 | -17.35 |
Total Total Growth | 887.61 | 886.62 | 883.31 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 915.86 | 925.71 | 805.92 | 745 | 617.73 | 695.84 |
Total Debt Total Debt Growth | 484.57 | 485.13 | 224.24 | 347.91 | 411.99 | 633.09 |
Net Cash (Debt) Net Cash Growth | 431.29 | 440.57 | 581.69 | 397.09 | 205.74 | 62.75 |
Net Cash Growth | -37.55% | -24.26% | 46.49% | 93.01% | 227.89% | -31.96% |
Net Cash Per Share Net Cash Per Share Growth | 5.60 | 5.73 | 7.81 | 5.19 | 2.76 | 0.88 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 57.27 | 123.99 | 269.87 | 272.01 | 181.99 | 98.51 |
Capital Expenditures CapEx Growth | -90.91 | -101.53 | -34.76 | -14.73 | -14.96 | -25.78 |
Free Cash Flow Free Cash Flow Growth | -33.64 | 22.46 | 235.11 | 257.28 | 167.03 | 72.73 |
Free Cash Flow Growth | - | -90.45% | -8.62% | 54.04% | 129.64% | 21.97% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 72.27% | 72.00% | 74.23% | 71.88% | 66.72% | 67.62% |
Operating Margin | 16.97% | 21.42% | 28.09% | 28.00% | 24.15% | 24.12% |
Pretax Margin | 16.56% | 20.87% | 33.01% | 29.45% | 31.14% | 22.96% |
Profit Margin | 14.36% | 18.31% | 27.43% | 24.95% | 25.43% | 20.12% |
FCF Margin | -3.79% | 2.53% | 26.62% | 36.08% | 29.97% | 14.39% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 3.250 | - | 3.250 | 2.500 | 2.000 | 1.420 |
Dividend Per Share Growth | -66.20% | - | 30.00% | 25.00% | 40.84% | 60.49% |
Dividend Yield | 6.61% | - | 3.34% | 3.52% | 4.12% | 3.31% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 28.66 | 32.28 | 30.82 | 29.54 | 25.32 | 32.28 |
Forward PE | - | 19.12 | 16.10 | 20.85 | 20.85 | 20.85 |
P/FCF Ratio | - | 233.32 | 31.76 | 20.42 | 21.48 | 45.14 |
PS Ratio | 4.14 | 5.91 | 8.45 | 7.37 | 6.44 | 6.49 |